Drug Financial Statements From 2010 to 2025
| DSOL Stock | USD 0 0.00 0.00% |
Check Drug Free financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Drug Free's main balance sheet or income statement drivers, such as , as well as many indicators such as . Drug financial statements analysis is a perfect complement when working with Drug Free Valuation or Volatility modules.
Drug |
Drug Free Solution Company Shares Outstanding Analysis
Drug Free's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Drug Free Shares Outstanding | 35.94 M |
Most of Drug Free's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Drug Free Solution is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Drug Free Solution has 35.94 M of shares currently outstending. This is 80.09% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 93.71% higher than that of the company.
Drug Free Solution Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Drug Free's current stock value. Our valuation model uses many indicators to compare Drug Free value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Drug Free competition to find correlations between indicators driving Drug Free's intrinsic value. More Info.Drug Free Solution is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Drug Free's earnings, one of the primary drivers of an investment's value.About Drug Free Financial Statements
Drug Free investors utilize fundamental indicators, such as revenue or net income, to predict how Drug Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. DRUG FREE is traded on PNK Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.